Gastric Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
I
Not yet recruiting
  • Gastric Cancer
  • +2 more
  • Doxorubicin and Cisplatin
  • London, United Kingdom
    Imperial College London, Hammersmith Hospital Campus
2022-04-01
Apr 1, 2022
N
Recruiting
  • Gastric Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Not yet recruiting
    • Gastric Cancer
    • +2 more
    • Cellvizio (Registered trademark) 100 microscope
    • Olympus GIF 180 endoscope
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Recruiting
    • Gastric Adenocarcinoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    S
    Active, not recruiting
    • Gastrointestinal Cancer
    • +8 more
    • Serious Illness Conversation Guide (SICG)
    • Quality of Life (QOL) survey
    • Stanford, California
      Stanford Cancer Center
    2022-04-05
    Apr 5, 2022
    N
    Recruiting
    • Gastrointestinal Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Recruiting
    • Gastric Adenocarcinoma
    • +2 more
    • Surgery
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    N
    Recruiting
    • Pancreatic Cancer
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2022-04-07
    Apr 7, 2022
    E
    No longer available
    • Gastric Cancer
    • Gastroesophageal Junction Adenocarcinoma
    • (no location specified)
    2022-04-06
    Apr 6, 2022
    N
    Enrolling by invitation
    • Esophageal Cancer
    • Gastric Cancer
      • Beijing, China
        Cancer Institute and hospital, Chinese Academy of Medical Scienc
      2022-04-07
      Apr 7, 2022
      M
      Active, not recruiting
      • Breast Cancer
      • Gastric Cancer
      • margetuximab
      • Bethesda, Maryland
      • +2 more
      2022-04-05
      Apr 5, 2022
      H
      Recruiting
      • Gastric Cancer
      • +8 more
      • Los Angeles, California
      • +2 more
      2022-04-05
      Apr 5, 2022
      Q
      Recruiting
      • Gastric Cancer
      • Jinan, Shandong, China
        Qilu hospital of Shandong univertisy
      2022-03-30
      Mar 30, 2022
      N
      Recruiting
      • Pancreatic Cancer
      • +15 more
      • Grand Rapids, Michigan
      • +2 more
      2022-04-05
      Apr 5, 2022
      A
      Active, not recruiting
      • Gastric Cancer
      • Anyang, Korea, Republic of
      • +13 more
      2022-04-05
      Apr 5, 2022
      S
      Completed
      • Gastric Cancer
      • Gastroesophageal Junction Cancer
      • Scottsdale, Arizona
      • +262 more
      2022-04-04
      Apr 4, 2022
      L
      Available
      • Esophageal Neoplasm
      • +9 more
      • Birmingham, Alabama
      • +3 more
      2022-04-05
      Apr 5, 2022
      D
      Recruiting
      • Liver Metastases
      • +10 more
      • DNX-2440
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute, Inc.
      2022-03-28
      Mar 28, 2022
      N
      Recruiting
      • Gastric Cancer
      • Prehabilitation
      • Vilnius, Lithuania
      • +1 more
      2022-04-05
      Apr 5, 2022
      S
      Withdrawn
      • Peritoneal Carcinomatosis
      • +6 more
      • anti-CEA CAR-T cells
      • New Brunswick, New Jersey
      • +1 more
      2022-03-25
      Mar 25, 2022
      K
      Completed
      • Gastric Cancer
      • Complication of Surgical Procedure
      • No use of antimicrobial prophylaxis
      • Use of antimicrobial prophylaxis
      • Hwasun, Jellanamdo, Korea, Republic of
        Chonnam National University Hwasun Hospital
      2022-03-28
      Mar 28, 2022
      D
      Active, not recruiting
      • Gastric Cancer
      • Esophagus Cancer
      • Clayton, North Carolina
      • +6 more
      2022-03-28
      Mar 28, 2022
      N
      Not yet recruiting
      • Pancreatic Cancer
      • +15 more
      • (no location specified)
      2022-03-27
      Mar 27, 2022